Clindamycin phosphate in dextrose 5% is an intravenous antibiotic solution used to treat serious infections caused by susceptible anaerobic bacteria [1]. It is administered as an infusion [2].
What infections does clindamycin phosphate in dextrose 5% treat?
This medication is indicated for the treatment of serious infections caused by anaerobic bacteria. These include, but are not limited to, infections of the abdomen, pelvis, and female reproductive tract, as well as certain skin and soft tissue infections and bacterial pneumonia and empyema [1].
How is clindamycin phosphate administered?
Clindamycin phosphate is given intravenously as an infusion. The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's condition [2].
Are there any alternatives to clindamycin phosphate for treating anaerobic infections?
While clindamycin is effective against many anaerobic bacteria, other antibiotics may also be used depending on the specific pathogen and clinical scenario. For instance, metronidazole is another common choice for anaerobic infections. The choice of antibiotic is typically guided by susceptibility testing and clinical guidelines [1].
What are the potential risks or side effects of clindamycin phosphate?
A significant risk associated with clindamycin, like other antibiotics, is the development of Clostridioides difficile-associated diarrhea (CDAD), which can range in severity from mild diarrhea to fatal colitis [1]. Other potential side effects can include nausea, vomiting, diarrhea, abdominal pain, and hypersensitivity reactions. Rare but serious side effects like Stevens-Johnson syndrome have also been reported [2].
When does the patent for clindamycin phosphate expire?
Clindamycin is a well-established antibiotic, and its original patents have long expired. This means that generic versions have been available for many years [3]. Information on specific innovator drug patents and their expiry dates can be found on resources like DrugPatentWatch.com [4].
What are the pricing considerations for clindamycin phosphate?
As clindamycin phosphate is available in generic form, its pricing is generally competitive. The cost can vary depending on the manufacturer, dosage, and quantity purchased, as well as the healthcare setting and insurance coverage [3].
Who manufactures clindamycin phosphate?
Numerous pharmaceutical companies manufacture generic clindamycin phosphate solutions for intravenous administration.
What is the mechanism of action of clindamycin?
Clindamycin phosphate is a lincosamide antibiotic. It works by inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit of susceptible bacteria [1]. This action prevents the bacteria from growing and multiplying [1][2].
What clinical data supports the use of clindamycin phosphate?
Clinical trials have demonstrated the efficacy of clindamycin in treating various anaerobic bacterial infections. Its use is supported by extensive clinical experience and published literature detailing its effectiveness and safety profile [1].
---
Sources:
[1] Drug Information Provided by Lexicomp
[2] Clindamycin Phosphate Injection Information
[3] Generic Drug Information
[4] https://drugpatentwatch.com/